All News

FDA has revoked it's emergency use authorization for hydroxychloroquine in COVID-19. "CQ and HCQ are unlikely to be effective in treating COVID-19 for the authorized uses .... (and)..in light of ongoing serious cardiac adverse events and other serious AE" https://t.co/TrzJQVzsv7

Links:

https://bit.ly/2C2ZPR8

Dr. John Cush RheumNow ( View Tweet)

Jun 15, 2020

Rheumatology Round-Up from #EULAR2020 w/ Drs. Kavanaugh & Cush. Watch it on RheumNow https://t.co/5v9BTuLrPX or listen to the podcast on iTunes https://t.co/FHJv01AAbC or on Android Sound Cloud https://t.co/nb7iXdRMMb

Links:

https://bit.ly/2UECnA8

Dr. John Cush RheumNow ( View Tweet)

Jun 14, 2020

Links:

https://bit.ly/2WXXRIy

Dr. John Cush RheumNow ( View Tweet)

Jun 14, 2020

Links:

https://bit.ly/3hpmGqs

Dr. John Cush RheumNow ( View Tweet)

Jun 14, 2020

EULAR 2020 - Top 5 Abstracts

Save

d Jack Cush, MD

Jun 12, 2020

In no particular order, these are my top 5 presentations from this year's EULAR 2020 meeting. Congratulations to EULAR for pulling off the educational coup of the year by transforming their world class gigantic Frankfurt meeting into a worldwide virtual meeting in less than 8 weeks – KUDOS!

Read Article

Virtual EULAR 2020 Round Up

Save

d Jack Cush, MD

Jun 12, 2020

In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include the SELECT-CHOICE study, the EXCEED trial, Avacopan in AAV, BeST mortality outcomes, BLISS-LN study, biosimilars and tofa in systemic sclerosis.

Read Article

Day 4 - Top 3 from EULAR 2020

Save

d Jack Cush, MD

Jun 11, 2020

These were my top abstracts from Thursday, 4th of June at EULAR 2020:

Read Article

Day 3 - Top 5 from EULAR 2020

Save

d Jack Cush, MD

Jun 10, 2020

These were my top abstracts from Thursday, 4th of June at EULAR 2020:

Read Article

Year of the Wolf: Lupus at EULAR2020

Save

d Kathryn H. Dao, M.D.

Jun 10, 2020

For a disease that has been recognized since the days of Hippocrates, we are finally making some progress towards understanding systemic lupus erythematosus (SLE) and how to tame the wolf. Listed below are the top 5 studies and their summaries presented at the recent EULAR e-Congress confer

Read Article

Serum calprotectin: a better biomarker in ANCA-associated vasculitis?

Save

d David Liew, FRACP

Jun 10, 2020

Flares in ANCA-associated vasculitis are difficult to predict, but serum calprotectin may help predict relapse and renal failure, according to data presented at the EULAR 2020 virtual meeting this week.

Read Article

Day 1 Top 5 - EULAR2020

Save

d Jack Cush, MD

Jun 08, 2020

Here is my top-five from day one at EULAR:

Read Article

How do you approach your PsA patients with suboptimal response to MTX in moderate doses?

Olga Petryna DrPetryna ( View Tweet)

Jun 07, 2020

#EULAR2020 #op0050 RCT ph4 results: in inadequately controlled PsA addition of ADA results in better outcomes in terms MDA, ACR20, PASI75, HAQ-DI&LEI as opposed to MTX dose escalation @RheumNow https://t.co/iMgCkRawCl

Olga Petryna DrPetryna ( View Tweet)

Jun 07, 2020

#EULAR2020 #LB0001 SELECT-PsA-1 Upadacitinib vs PBO vs ADA: UPA 15/30 mg non-inferior &UPA 30 superior to ADA for ACR20. At wk12 ACR 20 70.6% UPA15, 78.5% UPA30 vs 36.2%PBO & 65%ADA. Better ACR50/70 &MDA va PBO. No new safety signals. @RheumNow https://t.co/QZkMdoqXEC

Olga Petryna DrPetryna ( View Tweet)

Jun 07, 2020

#EULAR2020 #op0028 12 wk ph3 RELIEF study: Apremilast effectively relieves OU pain and OU number after 12 wks of 30 mg bid Rx. Great proportion of APR PTs achieved >10 mm &>30 mm improvement in OU pain @RheumNow https://t.co/p71sz9XL0e

Olga Petryna DrPetryna ( View Tweet)

Jun 07, 2020

Lots of talk about best bDMARDs in RA-ILD, but what about in RA-assoc bronchiectasis? @Yuz6Yusof found rituximab had better 'lung survival' vs TNFi (similar baseline stats) Something to consider in these difficult-to-treat pts? @LeedsBRC Newcastle THU0143 #EULAR2020 @RheumNow https://t.co/XpffkDNqhU

David Liew drdavidliew ( View Tweet)

Jun 07, 2020

For patients on bDMARDs having surgery, we worry about post-op delayed wound healing. In this Japanese cohort, TCZ use was a risk factor. Unclear if meds withheld, but given IL-6 upreg in wound healing, it's plausible TCZ might have worse outcomes?? SAT0047 #EULAR2020 @RheumNow https://t.co/HVIKPplwiA

David Liew drdavidliew ( View Tweet)

Jun 07, 2020

Hand OA Rx strikes out. HCQ Rx neg and colchicine Trial negative. I wouldn’t put hand OA as same category of no Rx as for SSc and Sjogrens but agree though nuts to crack @eular_org @CRASCRRheum @earlyarthritis #EULAR2020 https://t.co/QRe3UpKpbz

Links:

https://twitter.com/rheumnow/status/1269051282238701569

Janet Pope Janetbirdope ( View Tweet)

Jun 07, 2020

Awesome colchicine data from @CatherineL_Hill @samwhittle and others: Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH) Abstract FRI0399 #EULAR2020 @RheumNow https://t.co/NVw9fo55dc https://t.co/LfHZVQTwIf

Links:

EULAR Abstract Archive

Dr Philip Robinson philipcrobinson ( View Tweet)

Jun 07, 2020

#EULAR2020 THU0260 LESS IS BEST when it comes to steroids: Singapore 10 yr retrospect SLE study noted GCs dose is an independent predictor of mortality for hospitalized infection even when adjusted for disease activity.

k dao KDAO2011 ( View Tweet)

Jun 07, 2020

Topics